陈永飞,中国科学院合肥物质科学研究院健康与医学技术研究所创新药物研究中心副研究员。2010年获得兰州大学有机化学专业博士学位;2010-2012年在南京大学从事博士后研究;2012年加入中国科学院合肥物质科学研究院,历任助理研究员,副研究员。
药物化学
代表性论文
Zhi Huang; Juan Ge; Yongfei Chen; Fengming Zou; Qingwang Liu; Beilei Wang; Yangguo Zhou; Chao Wu; Wenchao Wang; Aoli Wang;* Jing Liu;* and Qingsong Liu*. Discovery of Novel Purine Derivatives as Potent and Orally Bioavailable PGK1 Inhibitors for the Treatment of InflammatoryBowel Disease.Journal of Medicinal Chemistry. 2025, 68, 21394−21411.
Yongfei Chen; Jiaxin Wu; Aoli Wang; Ziping Qi; Taoshan Jiang; Cheng Chen; Fengming Zou; Chen Hu; Wei Wang; Hong Wu; Zhenquan Hu; Wenchao Wang; Beilei Wang; Li Wang; Tao Ren; Shanchun Zhang; Qingsong Liu*; Jing Liu*. Discovery of N-(5-((5-chloro-4-((2- (isopropylsulfonyl)phenyl)amino) pyrimidin- 2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl) phenyl)acrylamide (CHMFL-ALK/ EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC, European Journal of Medicinal Chemistry, 2017, 139: 674-697.
Beilei Wang; Yuanxin Deng; Yongfei Chen; Kailin Yu; Aoli Wang; Qianmao Liang; Wei Wang; Cheng Chen; Hong Wu; Chen Hu; Weili Miao; Wooyoung Hur; Wenchao Wang; Zhenquan Hu; Ellen L. Weisberg; Jinhua Wang; Tao Ren; Yinsheng Wang; Nathanael S. Gray; Qingsong Liu*; Jing Liu*. Structure-activity relationship investigation for benzonaphthyridinone derivatives as novel potent Bruton's tyrosine kinase (BTK) irreversible inhibitors, European Journal of Medicinal Chemistry, 2017, 137: 545-557.
Qianmao Liang; Yongfei Chen; Kailin Yu; Cheng Chen; Shouxiang Zhang; Aoli Wang; Wei Wang; Hong Wu; Xiaochuan Liu; Beilei Wang; Li Wang; Zhenquan Hu; Wenchao Wang; Tao Ren; Shanchun Zhang; Qingsong Liu*; Cai-Hong Yun*; Jing Liu*. Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4- carbonyl) phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2- methylphenyl)-4-(tertbutyl) benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor, European Journal of Medicinal Chemistry, 2017, 131: 107-125.
H Wu; C Hu; A Wang; EL Weisberg; Y Chen; C-H Yun; W Wang; Y Liu; X Liu; B Tian; J Wang; Z Zhao; Y Liang; B Li; L Wang; B Wang; C Chen; SJ Buhrlage; Z Qi; F Zou; A Nonami; Y Li; SM Fernandes; S Adamia; RM Stone; IA Galinsky; X Wang; G Yang; JD Griffin; JR Brown; MJ Eck; J Liu*; NS Gray*; Q Liu*. Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia, Leukemia, 2016, 30: 173-181.
专利
刘青松;刘静;陈永飞;黄志;葛娟;邹凤鸣;王傲莉;刘青旺;亓爽;齐紫平;吴宏;王文超;王蓓蕾;王黎;含有嘌呤环的化合物及其用途,2024-01-09,CN202410029938X
刘静;刘青松;梁前茅;陈永飞;陈程;王傲莉;吴宏;余凯琳;王伟;胡晨;王文超;亓爽;王蓓蕾;王黎;一种新型布鲁顿酪氨酸激酶不可逆抑制剂,2016-02-04,CN201610084082.1
刘青松;刘静;江桃山;王傲莉;吴佳昕;吴宏;齐紫平;陈永飞;邹凤鸣;王文超;赵铮;王黎;王蓓蕾;一种新型的EGFR/ALK激酶的双重抑制剂,2015-12-15,201510946305.6
刘青松;刘静;陈永飞;吴宏;王傲莉;王蓓蕾;胡晨;王文超;陈程;一种新型布鲁顿酪氨酸激酶抑制剂,2014-06-19,CN201410280931.1
承担项目
天然生物碱Lymphostin对mTOR激酶抑制的分子机理研究,安徽省自然科学基金面上项目,2015.05—2017.06